Reliability and validity of dermatology life quality index: assessment of quality of life in human immunodeficiency virus/acquired immunodeficiency syndrome patients with pruritic papular eruption

Journal of Traditional Chinese Medicine

Volumn 33, Issue 5, 2013, Pages 580-583

  Liu, Zhibin ^a,b   Xie, Zheng ^b   Zhang, Li ^b   Jin, Yantao ^b   Guo, Huijun ^b   Jiang, Ziqiang ^b   Chen, Xiumin ^b   Yuan, Jun ^b  

^a THE FIRST AFFILIATED HOSPITAL OF HENAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Key Lab of Viral Dis Prevention and Treatment of Traditional Chinese Medicine of Henan Province   (China)

Author keywords

Acquired immunodeficiency syndrome; Dermatology; HIV; Pruritic popular eruption; Quality of life

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS PATIENT; ARTICLE; CHINA; CRONBACH ALPHA COEFFICIENT; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PAPULAR RASH; PRINCIPAL COMPONENT ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; STATISTICAL ANALYSIS; VALIDITY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84887743650     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(14)60024-8     Document Type: Article

References (25)

1. Bureau of hygiene and tropical diseases. Weekly epidemiological record. AIDS Newsletter 1986; 61(29): 6.
2. State Council AIDS Working Committee Office, United Nations Theme Group on AIDS in China. A joint assessment of HIV/AIDS prevention, treatment and care in China. Beijing: Ministry of Health, 2007: 1-7.
3. Campos L N, César C C, Guimarães M D C. Quality of life among HIV-infected patients in Brazil after initiation of treatment. Clinics (Sao Paulo) 2009; 64(9): 867-875.
4. Garretsen H F L, Van Gilst E C H, Van Oers H A M. Collecting health information at a local level. Health Promot Interv 1991; 6(2): 121-133.
5. Finlay A Y, Khan G K. Dermatology life quality index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19(3): 210-216.
6. Chinese Medical Association and Chinese Center for Disease Control and Prevention. Guidelines for diagnosis and treatment of HIV/AIDS in China (2005). Chin Med J (Engl) 2006; 119(19): 1589-1608.
7. Yahya H. Change in pattern of skin disease in Kaduna, north-central Nigeria. Int J Dermatol 2007; 46(9): 936-943.
8. Resneck J S Jr, Van Beek M, Furmanski L, et al. Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA 2004; 292(21): 2614-2621.
9. Lakshmi S J, Rao G R, Rao K A, Prasad P, Kumar Y. Pruritic papular eruptions of HIV: a clinicopathologic and therapeutic study. Indian J Dermatol Venereol Leprol 2008; 74(5): 501-503.
10. Colebunders R, Mann J M, Francis H, et al. Generalized papular pruritic eruption in African patients with HIV infection. AIDS 1987; 1(2): 117-121.
11. Liautaud B, Pape J W, DeHovitz J A, et al. Pruritic skin lesions. A initial presentation of acquired immunodeficiency syndrome. Arch Dermatol 1989; 125(5): 629-632.
12. Eisman S. Pruritic papular eruptions of HIV-1. Dermatol Clin 2006; 24(4): 449-457.
13. Tan X, Feldman S R, Balkrishnan R. Quality of life issues and measurement in patients with psoriasis. Psoriasis: targets and therapy 2012; 2(1): 13-23.
14. Menter A, Augustin M, Signorovitch J, et al. The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. J Am Acad Dermatol 2010; 62(5): 812-818.
15. Ware J J, Gandek B. Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) project. J Clin Epidemiol 1998; 51(11): 903-912.
16. WHOQOL HIV Group. WHOQOL-HIV for quality of life assessment among people living with HIV and AIDS: results from the field test. AIDS Care 2004; 16(7): 882-889.
17. Spitzer W O, Dobson A J, Hall J, et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chron Dis 1981; 34(12): 585-597.
18. Gupta D, Lis C G, Grutsch J F. The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manage 2007; 34(1): 40-47.
19. Bronsard V, Paul C, Prey S, et al. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. JEADV 2010; 24(Suppl 2): 17-22.
20. Yang H Z, Wang K, Jin H Z, et al. Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis: a randomized, double-blind, placebo-controlled multicenter trial. Chin Med J (Engl) 2012; 125(11): 1845-1851.
21. Wang X L, Zhao T E, Zhang X Q. Assessment on the reliability and validity of the dermatology life quality index in Chinses version. Zhong Hua Liu Xing Bing Xue Za Zhi 2004; 25(9): 791-793.
22. Zhou Z L, Zhang J P, Wang X M, Shao Q, Hu J Y, Han Q D. Compliance of the patients and related influential factors on the topical antifungal treatment of onychomycosis. Zhong Hua Liu Xing Bing Xue Za Zhi 2011; 32(7): 720-723.
23. Quan Z, Luo X Q, Huang H Y, et al. Study on quality of life and influencing factors in patients with pemphigus and bullous pemphigoid. Chin J Derm Venereol 2010; 24(10): 928-923.
24. Wang K Y, Wang K H, Zhang Z P. Health-related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol 2011; 25(4): 429-435.
25. Zhou J, Ding Y F, Chu H, Yi X M, Lou W. Life quality and its influence factors in 107 cases of alopecia areata. Shanghai Yu Fang Yi Xue 2011; 23(2): 49-51.